U.S. News April 14, 2022
David Levine

Leaders are working together to address disparities and improve cardiovascular health for all.

“If significant changes are not made to curtail the rising incidence of cardiovascular disease, that burden is likely to overwhelm society,” especially among vulnerable populations, said Victor Bulto, head of U.S. Pharmaceuticals for Novartis Pharmaceuticals Corporation.

Heart disease has long been the No. 1 cause of death in the United States, accounting for approximately 1 in every 4 deaths each year, according to data from the Centers for Disease Control and Prevention. As with many health issues, heart disease can disproportionately affect certain demographic and socioeconomic groups, underscoring the sad adage that ZIP code is a primary risk factor for ill health.

“If significant changes are not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Equity/SDOH, Healthcare System, Patient / Consumer, Population Health Mgmt, Provider
Population Health Outcomes: The Impact of Social Determinants of Health and the Initiatives Being Implemented
Engaging Specialty Practices and Promoting Population Health
Why the RVU system makes attaining the quadruple aim laughable: a deep dive into a broken health care model
Population Health Strategies Are Vital for Tackling, Improving CKD Care
Top 9 population health platforms

Share This Article